The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia
Open Access
- 1 January 2009
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 33 (1), 142-147
- https://doi.org/10.1183/09031936.00167707
Abstract
Although the presence of neutropenia may predispose cancer patients to develop community-acquired pneumonia, the role of neutropenia on their outcomes has not been investigated. The purpose of the present study was to compare clinical outcomes of cancer community-acquired pneumonia patients with and without neutropenia. Patients with cancer, identified in the Community-Acquired Pneumonia Organization database, were divided into two groups according to the type of cancer and the presence of neutropenia: patients with solid cancer without neutropenia versus those with functional or absolute neutropenia. Among the 3,106 community-acquired pneumonia patients enrolled, 135 had cancer without neutropenia and 75 had cancer with neutropenia. No significant difference was found between patients with and without neutropenia regarding mean time to clinical stability (5.4±2.7 versus 4.9±2.7 days, respectively), mean length of hospital stay (9.2±7.7 versus 9.9±9.6 days) and in-hospital mortality (18 versus 15%, respectively). Using a multiple logistic regression model, neutropenia was not associated with mortality in cancer patients when adjusting for significant covariates (odds ratio 1.30). Lack of neutropenia, during the initial evaluation of a cancer community-acquired pneumonia patient, should not be considered an indicator of better clinical outcome.This publication has 12 references indexed in Scilit:
- Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Streptococcus pneumoniae Bacteremia in Patients With CancerMedicine, 2005
- Cancer patients with septic shock: mortality predictors and neutropeniaSupportive Care in Cancer, 2004
- Prognostic Factors of Non-HIV Immunocompromised Patients With Pulmonary InfiltratesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- Guidelines for the Management of Adults with Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Predictors of short-term mortality in critically ill patients with solid malignancies.Intensive Care Medicine, 2000
- Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unitCritical Care Medicine, 2000
- Fever in Immunocompromised PatientsThe New England Journal of Medicine, 1999
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Is intensive care justified for patients with haematological malignancies?Intensive Care Medicine, 1990